Market Overview

Vetr Issues Strong Buy As Teva Trends Down

Share:

The Vetr crowd on Thursday upgraded its rating for Teva Pharmaceutical Industries Limited (ADR) (NYSE: TEVA) from 3.5 stars (Buy), issued 15 days ago, to 4.5 stars (Strong Buy). Crowd sentiment at the time of the downgrade was mostly bullish, with 81 0percent of Vetr user ratings bullish.

Share price in the biotech company has been on the downtrend throughout most of 2017, experiencing small price bumps following average earnings reports in February and May, the latter of which revealed the company was $30 million shy of analyst sales estimates, but delivered $0.03 over the quarter's EPS estimate.

However, the stock has resumed its downward path, reaching a new 10-year low of $29.67 by the end of May 18.

Learn how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd's average target price for Teva is up at 34.25, which is still below the average analyst target price of $45.47. Less than 2 percent of Vetr users are holding TEVA in their watch lists.

Latest Ratings for TEVA

DateFirmActionFromTo
Jun 2020SunTrust Robinson HumphreyUpgradesHoldBuy
May 2020UBSMaintainsBuy
May 2020SVB LeerinkMaintainsMarket Perform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

 

Related Articles (TEVA)

View Comments and Join the Discussion!

Posted-In: VetrBiotech Upgrades Price Target Crowdsourcing Analyst Ratings General

Latest Ratings

StockFirmActionPT
SGHRosenblattInitiates Coverage On45.0
VECOOppenheimerInitiates Coverage On18.0
NVAXJP MorganUpgrades46.0
ARYAChardan CapitalInitiates Coverage On28.0
AMCImperial CapitalMaintains4.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com